Cefoperazone sodium salt
SIGMA/C4292 - 870 - 1015 μg/mg anhydrous basis
CAS Number: 62893-20-3
Empirical Formula (Hill Notation): C25H26N9NaO8S2
Molecular Weight: 667.65
EC Number: 263-751-5
MDL Number: MFCD07793331
Linear Formula: C25H26N9NaO8S2
Product Type: Chemical
| antibiotic activity spectrum | Gram-negative bacteria |
| Gram-positive bacteria | |
| assay | 870-1015 μg/mg (anhydrous basis) |
| form | powder or crystals |
| InChI | 1S/C25H27N9O8S2.Na/c1-3-3 |
| InChI key | NCFTXMQPRQZFMZ-WERGMSTESA |
| mode of action | cell wall synthesis | interferes |
| Quality Level | 200 ![]() |
| SMILES string | [Na+].CCN1CCN(C(=O)N[C@@H |
| storage temp. | 2-8°C |
| Application: | Cefoperazone is used to study drug-protein binding, expression and inhibition of penicillin-binding proteins (PBPs) during cell wall synthesis. |
| Biochem/physiol Actions: | Cefoperazone exerts its bactericidal effect by inhibiting the mucopeptide synthesis that affects the structure of bacterial cell wall. It has a dual excretory pattern, primarily via the biliary system and secondarily via the kidney. |
| General description: | Chemical structure: ß-lactam |
| Other Notes: | Keep container tightly closed in a dry and well-ventilated place. Keep in a dry place. |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H317 - H334 |
| Precautionary statements | P261 - P280 - P342 + P311 |
| Hazard Codes | Xn |
| Risk Statements | 42/43 |
| Safety Statements | 22-36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | 870-1015 μg/mg (anhydrous basis) |
| Storage Temp. | 2-8°C |
| UNSPSC | 51102829 |


